白血病树突状细胞疫苗的研究进展
摘要
对于难治性、复发性和老年性的白血病来说，寻找新的治疗方法尤为迫切。免疫治疗的目的就是能够激活患者体内的免疫反应，从而特异性地识别和杀伤癌细胞。而树突状细胞（DC）为强有力的抗原提呈细胞。抗原与DC结合成为肿瘤主动特异性免疫治疗的重要手段之一。本文在DC来源、抗原加载、成熟、输入、佐剂以及此疫苗的前景和存在的局限性等方面进行综述。
出处
《国际输血及血液学杂志》
CAS
2010年第1期49-56,共8页
International Journal of Blood Transfusion and Hematology
参考文献39
-
1Clark RE, Christmas SE. BCR-ABL fusion peptides and cytotoxic T cells in chronic myeloid leukaemia. J Leuk Lymphoma, 2001,42(5) :871-880.
-
2Moser M, Murphy KM. Dendritic cell regulation of TH1-TH2 development. Nat Immunol, 2000,1(3) : 199-205.
-
3Osada T, Clay TM, Woo CY, et al. Dendritic cell-based immunotherapy. Int Rev Immunol, 2006,25(5-6) :377-413.
-
4Curti A, Isidori A, Ferri E, et al. Generation of dendritic cells from positively selected CD14+ monocytes for anti-tumor immunotherapy. Leuk Lymphoma,2004,45(7):1419 1428.
-
5Santin AD, Bellone S, Palmieri M, et al. HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities. Gynecol Oncol, 2006,100(3) : 469-478.
-
6Crespo I, Paiva A, Couceiro A, et al. lmmunophenotypic and functional characterization of cord blood dendritic cells. Stem Cells Dev, 2004,13 (1) : 63-70.
-
7Klammer M, Waterfall M, Samuel K, et al. Fusion hybrids of dendritic cells and autologous myeloid blasts as a potential cellular vaccine for acute myeloid leukaemia. Br J Haematol, 2005; 129(3): 340 349.
-
8D'Amico G, Vulcano M, Bugarin C, et al. CD40 activation of BCP ALL cells generates IL-10-producing, IL-12-defective APCs that induce allogeneie T-cell anergy. Blood, 2004,104(3):744- 751.
-
9Janik JE, Miller LL, Kopp WC, et al. Treatment with tumor necrosis factoralpha and granulocyt e-macrophage colony- stimulating factor increases epidermal Langerhans' cell numbers in cancer patients. Clin lmmunol, 1999,93(3) : 209- 221.
-
10Streeter PR, Minster NI, Kahn LE, et al. Progenipoietins: Biological characterization of a family of dual agonists of fetal liver tyrosine kinase-3 and the granulocyte colony-stimulating factor receptor. Exp Hematol, 2001,29(1): 41- 50.
-
1刘剑勇,李挺.肿瘤疫苗的研究进展[J].中国医学文摘（肿瘤学）,2000,14(4):322-324. 被引量：1
-
2聂建梅,谷春霞,张振龙(综述).肿瘤疫苗的研究进展[J].国际生物制品学杂志,2011,34(2):86-90.
-
3张晓辉,孙强.乳腺癌疫苗的研究进展[J].中华临床医师杂志（电子版）,2012,6(12):134-135. 被引量：2
-
4吕方芳,洪小南,李进.树突状细胞疫苗研究进展[J].中国癌症杂志,2004,14(1):86-89. 被引量：1
-
5黄薇,李力,田厚文.子宫颈癌人乳头状瘤病毒疫苗的研究进展[J].国外医学（病毒学分册）,2003,10(3):70-74.
-
6阎玉英,樊婷婷.HPV疫苗的研究进展[J].首都医药,2012,19(4):23-24. 被引量：1
-
7吴勉云,伍欣星,邱惠.HPV相关肿瘤疫苗的研究进展[J].肿瘤防治杂志,2003,10(1):21-23. 被引量：2
-
8桂琳,李静,陈宝安.白血病树突状细胞体外培养影响因素的研究[J].中国实验血液学杂志,2010,18(6):1649-1653.
-
9杨博萍,李力.人乳头瘤病毒疫苗的研究进展及前景[J].中国妇幼健康研究,2010,21(6):839-841. 被引量：4
-
10方路,吴玉章.肿瘤基因疫苗的研究进展[J].免疫学杂志,2002,18(B06):124-127. 被引量：1
